Yimin Shi
Beijing, 100049, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Real-time cell barrier monitoring by spatial transepithelial electrical resistance measurement on a microelectrode array integrated Transwell.
Journal: Lab on a chip
Published: December 17, 2024
Exosomal membrane proteins analysis using a silicon nanowire field effect transistor biosensor.
Journal: Talanta
Published: May 17, 2024
A parylene-mediated plasmonic-photonic hybrid fiber-optic sensor and its instrumentation for miniaturized and self-referenced biosensing.
Journal: The Analyst
Published: March 20, 2023
Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-κB/NLRP3 Axis.
Journal: Journal of diabetes research
Published: June 06, 2022
Tangshenning Attenuates High Glucose-Induced Podocyte Injury via Restoring Autophagy Activity through Inhibiting mTORC1 Activation.
Journal: Journal of diabetes research
Published: August 03, 2021
Ginsenoside Rg1 Alleviates Podocyte Injury Induced by Hyperlipidemia via Targeting the mTOR/NF-κB/NLRP3 Axis.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: April 26, 2020
Ginsenoside Rg1 Alleviates Podocyte EMT Passage by Regulating AKT/GSK3 β/β-Catenin Pathway by Restoring Autophagic Activity.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: June 18, 2019
Calpain-10 drives podocyte apoptosis and renal injury in diabetic nephropathy.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: May 31, 2019
Astragaloside IV inhibits glucose-induced epithelial-mesenchymal transition of podocytes through autophagy enhancement via the SIRT-NF-κB p65 axis.
Journal: Scientific reports
Published: September 03, 2018
Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice.
Journal: Drug design, development and therapy
Published: August 21, 2018
Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy.
Journal: Drug design, development and therapy
Published: July 24, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026